MMP2 (matrix metallopeptidase 2)
|
Gene
|
Entrez ID
Entrez Gene ID - the GENE ID in NCBI Gene database.
|
4313 |
Gene nameGene Name - the full gene name approved by the HGNC.
|
Matrix metallopeptidase 2 |
Gene symbolGene Symbol - the official gene symbol approved by the HGNC, which is a short abbreviated form of the gene name.
|
MMP2 |
SynonymsGene synonyms aliases
|
CLG4, CLG4A, MMP-2, MMP-II, MONA, TBE-1 |
ChromosomeChromosome number
|
16 |
Chromosome locationChromosomal Location - indicates the cytogenetic location of the gene or region on the chromosome.
|
16q12.2 |
SummarySummary of gene provided in NCBI Entrez Gene.
|
This gene is a member of the matrix metalloproteinase (MMP) gene family, that are zinc-dependent enzymes capable of cleaving components of the extracellular matrix and molecules involved in signal transduction. The protein encoded by this gene is a gelatinase A, type IV collagenase, that contains three fibronectin type II repeats in its catalytic site that allow binding of denatured type IV and V collagen and elastin. Unlike most MMP family members, activation of this protein can occur on the cell membrane. This enzyme can be activated extracellularly by proteases, or, intracellulary by its S-glutathiolation with no requirement for proteolytical removal of the pro-domain. This protein is thought to be involved in multiple pathways including roles in the nervous system, endometrial menstrual breakdown, regulation of vascularization, and metastasis. Mutations in this gene have been associated with Winchester syndrome and Nodulosis-Arthropathy-Osteolysis (NAO) syndrome. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Oct 2014] |
SNPsSNP information provided by dbSNP.
|
SNP ID |
Visualize variation |
Clinical significance |
Consequence |
rs41459945 |
G>A,C |
Uncertain-significance, conflicting-interpretations-of-pathogenicity |
Missense variant, coding sequence variant |
rs121912953 |
G>A |
Pathogenic |
Coding sequence variant, missense variant |
rs121912954 |
C>A,G |
Pathogenic |
Coding sequence variant, stop gained |
rs121912955 |
G>A |
Pathogenic |
Coding sequence variant, missense variant |
rs140172728 |
G>A |
Conflicting-interpretations-of-pathogenicity, uncertain-significance |
Synonymous variant, coding sequence variant |
rs148801200 |
C>A,T |
Conflicting-interpretations-of-pathogenicity |
Coding sequence variant, missense variant, synonymous variant |
rs786205497 |
G>A |
Likely-pathogenic |
Coding sequence variant, missense variant |
rs794727275 |
C>- |
Pathogenic |
Coding sequence variant, frameshift variant |
rs794727916 |
G>- |
Pathogenic |
Coding sequence variant, frameshift variant |
rs1567378779 |
C>- |
Pathogenic |
Frameshift variant, coding sequence variant |
|
miRNAmiRNA information provided by mirtarbase database.
|
miRTarBase ID |
miRNA |
Experiments |
Reference |
MIRT005570 |
hsa-miR-29b-3p |
Luciferase reporter assay, qRT-PCR, Western blot |
20657750 |
MIRT005570 |
hsa-miR-29b-3p |
Western blot |
23254643 |
MIRT005570 |
hsa-miR-29b-3p |
Western blot |
24130681 |
MIRT005570 |
hsa-miR-29b-3p |
Immunofluorescence, Immunohistochemistry, Luciferase reporter assay, Northern blot, qRT-PCR, Western blot |
24130168 |
MIRT005570 |
hsa-miR-29b-3p |
Microarray |
22942087 |
MIRT005570 |
hsa-miR-29b-3p |
Western blot |
24147037 |
MIRT005570 |
hsa-miR-29b-3p |
Luciferase reporter assay, qRT-PCR |
23354167 |
MIRT005570 |
hsa-miR-29b-3p |
Luciferase reporter assay |
22745231 |
MIRT005570 |
hsa-miR-29b-3p |
Luciferase reporter assay, qRT-PCR, Western blot |
26063204 |
MIRT005742 |
hsa-miR-451a |
qRT-PCR, Western blot |
20816946 |
MIRT005742 |
hsa-miR-451a |
qRT-PCR, Western blot |
27173190 |
MIRT018099 |
hsa-miR-335-5p |
Microarray |
18185580 |
MIRT019228 |
hsa-miR-338-3p |
Western blot;qRT-PCR |
21671467 |
MIRT030716 |
hsa-miR-21-5p |
qRT-PCR |
19435867 |
MIRT031370 |
hsa-miR-17-5p |
Western blot |
20209605 |
MIRT053245 |
hsa-miR-29c-3p |
qRT-PCR, Western blot |
23175151 |
MIRT053245 |
hsa-miR-29c-3p |
Immunofluorescence, Immunohistochemistry, Luciferase reporter assay, Northern blot, qRT-PCR, Western blot |
24130168 |
MIRT053245 |
hsa-miR-29c-3p |
Luciferase reporter assay, qRT-PCR, Western blot |
23936390 |
MIRT053245 |
hsa-miR-29c-3p |
Luciferase reporter assay |
22745231 |
MIRT053336 |
hsa-miR-491-5p |
Immunohistochemistry, Microarray, qRT-PCR, Western blot |
23725476 |
MIRT053481 |
hsa-miR-9-5p |
qRT-PCR |
21931274 |
MIRT053580 |
hsa-miR-29a-3p |
Immunofluorescence, Immunohistochemistry, Luciferase reporter assay, Northern blot, qRT-PCR, Western blot |
24130168 |
MIRT053580 |
hsa-miR-29a-3p |
Flow, Luciferase reporter assay, qRT-PCR, Western blot |
24210072 |
MIRT053580 |
hsa-miR-29a-3p |
Luciferase reporter assay |
22745231 |
MIRT053580 |
hsa-miR-29a-3p |
Luciferase reporter assay |
26700017 |
MIRT053787 |
hsa-miR-452-5p |
Microarray, qRT-PCR |
22952876 |
MIRT437388 |
hsa-miR-708-5p |
Flow, qRT-PCR, Western blot |
23754151 |
MIRT437572 |
hsa-miR-767-5p |
Luciferase reporter assay |
22745231 |
MIRT438153 |
hsa-miR-106b-5p |
Luciferase reporter assay |
24164962 |
MIRT438234 |
hsa-miR-221-3p |
Western blot |
24147037 |
MIRT440222 |
hsa-miR-544a |
HITS-CLIP |
24374217 |
MIRT724933 |
hsa-miR-1238-3p |
HITS-CLIP |
19536157 |
MIRT724934 |
hsa-miR-670-3p |
HITS-CLIP |
19536157 |
MIRT724935 |
hsa-miR-29b-2-5p |
HITS-CLIP |
19536157 |
MIRT724936 |
hsa-miR-6749-3p |
HITS-CLIP |
19536157 |
MIRT724937 |
hsa-miR-6792-3p |
HITS-CLIP |
19536157 |
MIRT724938 |
hsa-miR-4691-5p |
HITS-CLIP |
19536157 |
MIRT731061 |
hsa-miR-130b-3p |
qRT-PCR, Luciferase reporter assay, Western blot |
25154741 |
MIRT731453 |
hsa-miR-125b-5p |
Luciferase reporter assay |
27133077 |
MIRT732848 |
hsa-miR-520g-3p |
In situ hybridization, Luciferase reporter assay, qRT-PCR, Western blot |
28292471 |
MIRT733143 |
hsa-miR-524-5p |
qRT-PCR, Western blot |
26998102 |
MIRT733418 |
hsa-miR-302a-5p |
ELISA, Western blot |
26191138 |
MIRT734261 |
hsa-miR-218-5p |
qRT-PCR, Western blot |
26133092 |
MIRT734404 |
hsa-miR-203a-5p |
Western blot |
26278219 |
MIRT734784 |
hsa-miR-143-3p |
qRT-PCR, Western blot |
26722463 |
MIRT734996 |
hsa-miR-519d-3p |
Luciferase reporter assay |
25803859 |
|
Transcription factors
|
|
Gene ontology (GO)Gene ontology information of associated ontologies with gene provided by GO database.
|
GO ID |
Ontology |
Definition |
Evidence |
Reference |
GO:0001525 |
Process |
Angiogenesis |
IEA |
|
GO:0001666 |
Process |
Response to hypoxia |
IBA |
21873635 |
GO:0001955 |
Process |
Blood vessel maturation |
IEA |
|
GO:0001957 |
Process |
Intramembranous ossification |
IEA |
|
GO:0004175 |
Function |
Endopeptidase activity |
IDA |
23845380 |
GO:0004222 |
Function |
Metalloendopeptidase activity |
IBA |
21873635 |
GO:0004222 |
Function |
Metalloendopeptidase activity |
TAS |
|
GO:0004252 |
Function |
Serine-type endopeptidase activity |
EXP |
17428795 |
GO:0004252 |
Function |
Serine-type endopeptidase activity |
TAS |
|
GO:0005515 |
Function |
Protein binding |
IPI |
12032297, 20979576, 21441952, 25613181, 25897080, 28106549, 28514442, 32296183, 32814053 |
GO:0005576 |
Component |
Extracellular region |
TAS |
|
GO:0005615 |
Component |
Extracellular space |
HDA |
20551380 |
GO:0005615 |
Component |
Extracellular space |
IDA |
18492766, 24236012, 24784232 |
GO:0005634 |
Component |
Nucleus |
IEA |
|
GO:0005739 |
Component |
Mitochondrion |
IEA |
|
GO:0005886 |
Component |
Plasma membrane |
IEA |
|
GO:0006508 |
Process |
Proteolysis |
IDA |
15863497 |
GO:0007566 |
Process |
Embryo implantation |
IEA |
|
GO:0008237 |
Function |
Metallopeptidase activity |
IDA |
24236012 |
GO:0008270 |
Function |
Zinc ion binding |
IEA |
|
GO:0019221 |
Process |
Cytokine-mediated signaling pathway |
TAS |
|
GO:0022617 |
Process |
Extracellular matrix disassembly |
TAS |
24970228 |
GO:0030017 |
Component |
Sarcomere |
IEA |
|
GO:0030198 |
Process |
Extracellular matrix organization |
IBA |
21873635 |
GO:0030574 |
Process |
Collagen catabolic process |
IBA |
21873635 |
GO:0030574 |
Process |
Collagen catabolic process |
TAS |
|
GO:0034614 |
Process |
Cellular response to reactive oxygen species |
IEA |
|
GO:0035987 |
Process |
Endodermal cell differentiation |
IEP |
23154389 |
GO:0044267 |
Process |
Cellular protein metabolic process |
TAS |
|
GO:0048013 |
Process |
Ephrin receptor signaling pathway |
TAS |
|
GO:0048771 |
Process |
Tissue remodeling |
IBA |
21873635 |
GO:0060325 |
Process |
Face morphogenesis |
IEA |
|
GO:0060346 |
Process |
Bone trabecula formation |
IEA |
|
GO:0062023 |
Component |
Collagen-containing extracellular matrix |
HDA |
23979707 |
GO:0062023 |
Component |
Collagen-containing extracellular matrix |
HDA |
28327460 |
GO:0071230 |
Process |
Cellular response to amino acid stimulus |
IEA |
|
GO:0071492 |
Process |
Cellular response to UV-A |
IDA |
31380578 |
GO:1904645 |
Process |
Response to amyloid-beta |
ISS |
|
GO:1904707 |
Process |
Positive regulation of vascular associated smooth muscle cell proliferation |
IMP |
18667463 |
|
Other IDsOther ids provides unique ids of gene in databases such as OMIM, HGNC, ENSEMBLE.
|
|
Protein
|
UniProt ID |
P08253 |
Protein name |
72 kDa type IV collagenase (EC 3.4.24.24) (72 kDa gelatinase) (Gelatinase A) (Matrix metalloproteinase-2) (MMP-2) (TBE-1) [Cleaved into: PEX] |
Protein function |
Ubiquitinous metalloproteinase that is involved in diverse functions such as remodeling of the vasculature, angiogenesis, tissue repair, tumor invasion, inflammation, and atherosclerotic plaque rupture. As well as degrading extracellular matrix proteins, can also act on several nonmatrix proteins such as big endothelial 1 and beta-type CGRP promoting vasoconstriction. Also cleaves KISS at a Gly-|-Leu bond. Appears to have a role in myocardial cell death pathways. Contributes to myocardial oxidative stress by regulating the activity of GSK3beta. Cleaves GSK3beta in vitro. Involved in the formation of the fibrovascular tissues in association with MMP14.; PEX, the C-terminal non-catalytic fragment of MMP2, posseses anti-angiogenic and anti-tumor properties and inhibits cell migration and cell adhesion to FGF2 and vitronectin. Ligand for integrinv/beta3 on the surface of blood vessels.; [Isoform 2]: Mediates the proteolysis of CHUK/IKKA and initiates a primary innate immune response by inducing mitochondrial-nuclear stress signaling with activation of the pro-inflammatory NF-kappaB, NFAT and IRF transcriptional pathways. |
PDB |
1CK7
,
1CXW
,
1EAK
,
1GEN
,
1GXD
,
1HOV
,
1J7M
,
1KS0
,
1QIB
,
1RTG
,
3AYU
|
Family and domains |
Pfam
Accession |
ID |
Position in sequence |
Description |
Type |
PF01471 |
PG_binding_1 |
43 → 97 |
Putative peptidoglycan binding domain |
Domain |
PF00413 |
Peptidase_M10 |
118 → 446 |
Matrixin |
Domain |
PF00040 |
fn2 |
233 → 274 |
Fibronectin type II domain |
Domain |
PF00040 |
fn2 |
291 → 332 |
Fibronectin type II domain |
Domain |
PF00040 |
fn2 |
349 → 390 |
Fibronectin type II domain |
Domain |
PF00045 |
Hemopexin |
475 → 518 |
Hemopexin |
Repeat |
PF00045 |
Hemopexin |
520 → 563 |
Hemopexin |
Repeat |
PF00045 |
Hemopexin |
568 → 615 |
Hemopexin |
Repeat |
PF00045 |
Hemopexin |
617 → 660 |
Hemopexin |
Repeat |
|
Sequence |
|
Sequence length |
660 |
Interactions |
View interactions |
|
|